GlycoNet startup PanTHERA CryoSolutions receives 2024 Technology Innovation Award

Congratulations to the PanTHERA Cryosolutions team on receiving the 2024 Technology Innovation Award.    

 Posted: 27 September, 2024

Dr. Jason Acker (left) and Dr. Robert Ben (right), co-founders of PanTHERA Cryosolutions
 

BioAlberta announced the recipients of the 2024 Achievement Awards at the Health and Life Sciences Showcases and Awards Dinner at the University of Calgary Downtown Campus on September 26th, 2024. GlycoNet startup company, PanTHERA CryoSolutions Inc., was the recipient of the 2024 Technology Innovation Award. 

The Technology Innovation Award recognizes individuals and teams for their exceptional contributions to the life sciences industry, inspiring new ways of thinking and advancing innovative solutions. 

PanTHERA CryoSolutions, a pioneering leader in cryopreservation technology, was honoured for its groundbreaking work in developing Ice Recrystallization Inhibitors (IRIs)—a first-of-its-kind advancement that is set to revolutionize the field of cryobiology. IRIs effectively prevent the growth of ice crystals during freezing and thawing processes, addressing a key challenge in cryopreservation. This innovation significantly minimizes cellular damage, enhancing the viability and functionality of cryopreserved materials for a wide range of applications, from biomedical research to biobanking. 

Drs. Jason Acker and Robert Ben, both GlycoNet network investigators, co-founded PanTHERA Cryosolutions. Their leadership and commitment to advancing cryopreservation technology have had a transformative impact on the field. 

The Technology Innovation Award reflects PanTHERA’s commitment to advancing cryopreservation science, improving outcomes in biotechnology, and continuing its pursuit of excellence in the life sciences.

Related news:

 

 
Discover more from GlycoNet News.
Scroll to Top